Japanese CRO Acronet Enhances Collaboration With Other Itochu Medical Subsidiaries
This article was originally published in PharmAsia News
Executive Summary
Itochu contract research subsidiary Acronet plans to enter the Chinese CRO market and reach ¥10 billion in sales by 2013, disclosed the company's new president Shogo Nakamori